A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry
McQuilten ZK, Wood EM, Savoia H, Cole S,. A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry. Aust NZ J Obstet Gynaecol 2011; 51 (3): 191-198.
Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: Safe and effective
DOI 10.1111/j.1471-0528.2007.01244.x
van den Akker ES, Oepkes D, Lopriore E, et al. Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective. BJOG 2007; 114: 469-473. (Pubitemid 46393288)
The UK Obstetric Surveillance System for rare disorders of pregnancy
DOI 10.1111/j.1471-0528.2005.00609.x
Knight M, Kurinczuk JJ, Tuffnell D, Brocklehurst P,. The UK Obstetric Surveillance System for rare disorders of pregnancy. BJOG 2005; 112 (3): 263-265. (Pubitemid 40313997)
The incidence and outcomes of fetomaternal alloimmune thrombocytopenia: A UK national study using three data sources
Knight M, Pierce M, Allen D, et al. The incidence and outcomes of fetomaternal alloimmune thrombocytopenia: a UK national study using three data sources. Br J Haematol 2011; 152: 460-468.